These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma. Liu Y, Qiao Y, Zhou M, Guo J, Lin Y, Li W, An C, Li C. Cancer Med; 2023 Mar; 12(5):5436-5449. PubMed ID: 36254376 [Abstract] [Full Text] [Related]
32. [Preliminary clinical use of hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab in the treatment of unresectable intrahepatic cholangiocarcinoma]. Zhou BJ, Wang WS, Yin Y, Yang J, Zhu XL, Ni CF. Zhonghua Nei Ke Za Zhi; 2024 Aug 01; 63(8):769-775. PubMed ID: 39069865 [Abstract] [Full Text] [Related]
33. Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? Boerner T, Zambirinis C, Gagnière J, Chou JF, Gonen M, Kemeny NE, Cercek A, Connell LC, Kingham TP, Allen PJ, Balachandran VP, Drebin J, Jarnagin WR, D'Angelica MI. HPB (Oxford); 2021 Apr 01; 23(4):601-608. PubMed ID: 32943326 [Abstract] [Full Text] [Related]
37. Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study. Shiozawa K, Watanabe M, Ikehara T, Kogame M, Matsui T, Okano N, Kikuchi Y, Nagai H, Ishii K, Makino H, Igarashi Y, Sumino Y. Hepatogastroenterology; 2014 Jun 01; 61(132):885-91. PubMed ID: 26158136 [Abstract] [Full Text] [Related]
38. Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study. Zang M, Hu X, Yuan G, Li R, Li W, Pang H, Li Q, Chen J. Int Immunopharmacol; 2023 Dec 01; 125(Pt A):111019. PubMed ID: 37879230 [Abstract] [Full Text] [Related]
40. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Liu W, Wang H, Bao Q, Liu M, Hao C, Shen L, Xing B, Wang X. Radiology; 2022 May 01; 303(2):455-464. PubMed ID: 35103539 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]